Table 1 Basic characteristics of diabetic patients with and without CAN
Variables (mean ± SD) | Patients with CAN | Patients without CAN | P_value |
|---|---|---|---|
Age (years) | 49.81 ± 15.52 | 53.74 ± 11.95 | 0.35 |
Duration of DM (month) | 91.67 ± 73.17 | 80.37 ± 79.74 | 0.04 |
Fasting blood sugar (mg/dl) | 155.12 ± 81.03 | 178.35 ± 80.12 | 0.06 |
Blood sugar 2 h post prandial (mg/dl) | 215.14 ± 119.06 | 233.93 ± 100.67 | 0.08 |
HbA1C (%) | 7.50 ± 1.72 | 7.68 ± 1.43 | 0.21 |
BMI (kg/m2) | 28.06 ± 5.36 | 27.37 ± 4.22 | 0.05 |
Total cholesterol (mg/dl) | 220.40 ± 44.36 | 194.72 ± 48.26 | 0.01 |
Triglyceride (mg/dl) | 173.04 ± 93.31 | 163.26 ± 141.49 | 0.06 |
HDL-C (mg/dl) | 51.09 ± 32.87 | 48.80 ± 17.48 | 0.45 |
LDL-C (mg/dl) | 165.52 ± 95.56 | 119.78 ± 40.41 | < 0.01 |
24-h urine protein (mg) | 165.40 ± 472.29 | 88.71 ± 181.58 | 0.70 |
Drug history (N) | |||
 Glucose lowering agents | 0.54 | ||
  Oral agent | 44 | 32 |  |
  Insulin | 20 | 9 |  |
  Diet | 2 | 1 |  |
 Lipid lowering agents | 0.43 | ||
  Statins | 54 | 45 |  |
  Fibrate | 12 | 16 |  |
 Antiplatelete therapy |  | 0.32 | |
  Aspirin | 46 | 38 |  |
  Clopidogral | 9 | 6 |  |
History of disease (yes, N) | |||
 Current smoker | 5 | 4 | 0.52 |
 Hypertension | 24 | 14 | 0.64 |
 Myocardial infarction | 5 | 1 | 0.39 |
 Stroke | 4 | 2 | 0.54 |
 Carotid artery stenosis (> 50%) | 6 | 1 | 0.24 |
 Retinopathy | 12 | 7 | 0.40 |
 Peripheral neuropathy | 34 | 19 | 0.80 |